Carsten Fink, Yann Ménière, Andrew A. Toole, Reinhilde Veugelers 13 July 2022
Contents
Foreword
Introduction
Carsten Fink, Yann Ménière, Andrew A. Toole and Reinhilde Veugelers
Half I: Affect the world over: A lot similarity, some divergence
1 How the COVID-19 disaster affected worldwide mental property filings
Carsten Fink, Ryan Lamb, Bruno Le Feuvre and Hao Zhou
2 Immunity to the COVID-19 shock? The case of US innovation
Walter G. Park, Andrew A. Toole, Gerard Torres and Richard D. Miller
3 Affect of the COVID-19 pandemic on trademark exercise in Canada
Grey Barski, Alex Lehmann, Diego Santilli and Sean Martineau
4 COVID-19 and the evaluation of patent, trademark and industrial design functions in Brazil
Marina Filgueiras Jorge, Sergio M Paulino de Carvalho, Irene von der Weid, Fernando Linhares de Assis, Gustavo Travassos and Vera Pinheiro
5 Affect of the COVID-19 pandemic on patent exercise: Some proof from patent filings on the European Patent Workplace
Bettina Reichl and Marc Nicolas
6 The affect of COVID-19 and Singapore’s response
William Kwek, Jia Yi Ho, Wei En Thong, Tan Chor Kiang, Muhammad Bin Rahmat and Benjamin Mak
7 The COVID-19 affect on innovation in China
Can Huang and Yurong Zhang
8 COVID-19: Disaster or alternative? The case of South Korean innovation
Wonjoon Kim, Daehyun Kim and Taekyun Kim
9 Impacts of COVID-19 on R&D and patenting actions in Japan: Demand shocks, utility delay, and patent choice worth
Isamu Yamauchi, Sadao Nagaoka and Daisuke Miyazaki
10 The COVID-19 affect in Australia
Michael Falk, Haiyang Zhang, Brodie Dobson-Keeffe, Catriona Bruce and Pushpika Wijesinghe
Half II: Responses within the innovation ecosystem
11 Affect of COVID-19 on investments in digital applied sciences by SMEs within the EU and the US
Julie Delanote, Ilja Rudyk and Désirée Rückert
12 The COVID-19 pandemic and tutorial analysis enterprise
Kyle R. Myers
13 The facility of consideration: Early indications of how the COVID-19 pandemic has affected the route of scientific analysis within the life sciences
Karin Hoisl, Carolin Lerchenmüller, Marc Lerchenmueller and Leo Schmallenbach
14 COVID-19 and medical trials
Margaret Kyle
15 The brand new mRNA breakthrough know-how for vaccines: A fortunate shot?
Reinhilde Veugelers
16 COVID and the US artistic financial system: Provide, demand, and the hastening of the longer term
Joel Waldfogel
17 On-line consumption behaviour and the way infringement ranges modified throughout lockdown
UK Mental Property Workplace
18 The COVID-19 affect on creative earnings: Proof from Germany
Alexander Cuntz and Matthias Sahli
